This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Reinhard König: Innovator in Thrombolytic Therapy
Introduction
Reinhard König is a notable inventor based in San Carlos, CA (US). He has made significant contributions to the field of thrombolytic therapy, focusing on innovative methods to treat thromboembolic conditions. His work has the potential to improve patient outcomes in critical medical situations.
Latest Patents
König holds a patent titled "Method for treating thromboembolic conditions by inhibiting reocclusion via the use of multiple bolus administration of thrombolytically active proteins." This patent discusses therapeutic approaches that utilize thrombolytically active proteins to inhibit reocclusion in patients. The proteins are administered in two or more boli, enhancing the effectiveness of the treatment.
Career Highlights
Throughout his career, Reinhard König has been associated with Boehringer Mannheim GmbH, a company known for its advancements in medical technology and pharmaceuticals. His work at the company has allowed him to focus on developing innovative therapies that address complex medical challenges.
Collaborations
König has collaborated with various professionals in the field, including his coworker Ulrich Martin. These collaborations have fostered an environment of innovation and have contributed to the development of effective therapeutic solutions.
Conclusion
Reinhard König's contributions to thrombolytic therapy exemplify the impact of innovative thinking in medicine. His patent and work at Boehringer Mannheim GmbH highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
